Stocks to Watch: Gamestop, Universe Pharmaceuticals, Healthcare Triangle

Dow Jones
06/27
 

GameStop forecast a jump in adjusted earnings before interest, taxes, depreciation, and amortization for the current fiscal year. The company said it expects adjusted Ebitda for the fiscal year ending Jan. 30, 2027, to be upwards of $600 million, compared to $345.4 million for the previous fiscal year. The forecast comes after the company reported a higher profit and rising sales in its most recent quarter and approved a $2 billion stock buyback. Shares ticked up 2.2% to $22.24 in late trading.

Universe Pharmaceuticals agreed to acquire Best Praise International Limited in an all-stock deal valued at $10.8 million. Under the deal, which is expected to close in the third quarter, Universe will pay for the acquisition with about 4.8 million shares of its common stock. Shares of Universe more than tripled to $9.34 in after-hours trading.

Healthcare Triangle entered a securities exchange agreement related to its acquisition of SecureKloud Technologies's assets. The company said it agreed to issue about 2.8 million shares of its common stock to SecureKloud in exchange for all of SecureKloud's right, title and interest in the 1.6 million shares of Series B preferred stock that Healthcare Triangle had previously issued under a 2024 agreement. The stock gained in after-hours trading before turning negative, and were recently down 5.9% at $1.92.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

June 26, 2026 18:50 ET (22:50 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10